| WKN: | A0ET3D |
| ISIN: | GB00B0744359 |
| Land: | Großbritannien |
| Branche: | Chemie, Pharma, Bio- & Medizintechnik |
| Sektor: | Chemie |
Weshalb die Essentra-Aktie
ein D-Rating hat,
erfahren Sie im Performance-Check
vom 11. März 2026 Info.
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2009 | 1,07 | 1,75 | 63,55% |
| 2 | 2011 | 2,42 | 3,86 | 59,50% |
| 3 | 2013 | 5,76 | 8,76 | 52,08% |
| 4 | 2012 | 3,86 | 5,76 | 49,22% |
| 5 | 2019 | 3,07 | 4,32 | 40,72% |
| 6 | 2010 | 1,75 | 2,42 | 38,29% |
| 7 | 2015 | 8,19 | 9,88 | 20,63% |
| 8 | 2021 | 2,98 | 3,41 | 14,43% |
| 9 | 2017 | 4,56 | 5,01 | 9,87% |
| 10 | 2026 | 1,10 | 1,08 | -1,82% |
| 11 | 2006 | 3,49 | 3,31 | -5,16% |
| 12 | 2014 | 8,76 | 8,19 | -6,51% |
| 13 | 2023 | 2,24 | 1,88 | -16,07% |
| 14 | 2024 | 1,88 | 1,55 | -17,55% |
| 15 | 2025 | 1,55 | 1,10 | -29,03% |
| 16 | 2007 | 3,31 | 2,31 | -30,21% |
| 17 | 2020 | 4,32 | 2,98 | -31,02% |
| 18 | 2022 | 3,41 | 2,24 | -34,31% |
| 19 | 2018 | 5,01 | 3,07 | -38,72% |
| 20 | 2008 | 2,31 | 1,07 | -53,68% |
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2016 | 9,88 | 4,56 | -53,85% |
| 2 | 2008 | 2,31 | 1,07 | -53,68% |
| 3 | 2018 | 5,01 | 3,07 | -38,72% |
| 4 | 2022 | 3,41 | 2,24 | -34,31% |
| 5 | 2020 | 4,32 | 2,98 | -31,02% |
| 6 | 2007 | 3,31 | 2,31 | -30,21% |
| 7 | 2025 | 1,55 | 1,10 | -29,03% |
| 8 | 2024 | 1,88 | 1,55 | -17,55% |
| 9 | 2023 | 2,24 | 1,88 | -16,07% |
| 10 | 2014 | 8,76 | 8,19 | -6,51% |
| 11 | 2006 | 3,49 | 3,31 | -5,16% |
| 12 | 2026 | 1,10 | 1,08 | -1,82% |
| 13 | 2017 | 4,56 | 5,01 | 9,87% |
| 14 | 2021 | 2,98 | 3,41 | 14,43% |
| 15 | 2015 | 8,19 | 9,88 | 20,63% |
| 16 | 2010 | 1,75 | 2,42 | 38,29% |
| 17 | 2019 | 3,07 | 4,32 | 40,72% |
| 18 | 2012 | 3,86 | 5,76 | 49,22% |
| 19 | 2013 | 5,76 | 8,76 | 52,08% |
| 20 | 2011 | 2,42 | 3,86 | 59,50% |